Literature DB >> 28620718

The phenotypic spectrum of ARHGEF9 includes intellectual disability, focal epilepsy and febrile seizures.

Karl Martin Klein1,2, Manuela Pendziwiat3, Anda Eilam4, Ronit Gilad4, Ilan Blatt5,6, Felix Rosenow7,8, Moien Kanaan9, Ingo Helbig3,10, Zaid Afawi5,11.   

Abstract

Mutations or structural genomic alterations of the X-chromosomal gene ARHGEF9 have been described in male and female patients with intellectual disability. Hyperekplexia and epilepsy were observed to a variable degree, but incompletely described. Here, we expand the phenotypic spectrum of ARHGEF9 by describing a large Ethiopian-Jewish family with epilepsy and intellectual disability. The four affected male siblings, their unaffected parents and two unaffected female siblings were recruited and phenotyped. Parametric linkage analysis was performed using SNP microarrays. Variants from exome sequencing in two affected individuals were confirmed by Sanger sequencing. All affected male siblings had febrile seizures from age 2-3 years and intellectual disability. Three developed afebrile seizures between age 7-17 years. Three showed focal seizure semiology. None had hyperekplexia. A novel ARHGEF9 variant (c.967G>A, p.G323R, NM_015185.2) was hemizygous in all affected male siblings and heterozygous in the mother. This family reveals that the phenotypic spectrum of ARHGEF9 is broader than commonly assumed and includes febrile seizures and focal epilepsy with intellectual disability in the absence of hyperekplexia or other clinically distinguishing features. Our findings suggest that pathogenic variants in ARHGEF9 may be more common than previously assumed in patients with intellectual disability and mild epilepsy.

Entities:  

Keywords:  ARHGEF9; Febrile seizures; Focal epilepsy; Genetic epilepsy; Intellectual disability

Mesh:

Substances:

Year:  2017        PMID: 28620718     DOI: 10.1007/s00415-017-8539-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  26 in total

1.  Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR.

Authors:  Hui Yang; Kai Wang
Journal:  Nat Protoc       Date:  2015-09-17       Impact factor: 13.491

2.  Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations.

Authors:  Stéphanie Baulac; Saeko Ishida; Elise Marsan; Catherine Miquel; Arnaud Biraben; Dang Khoa Nguyen; Doug Nordli; Patrick Cossette; Sylvie Nguyen; Virginie Lambrecq; Mihaela Vlaicu; Maïlys Daniau; Franck Bielle; Eva Andermann; Frederick Andermann; Eric Leguern; Francine Chassoux; Fabienne Picard
Journal:  Ann Neurol       Date:  2015-03-13       Impact factor: 10.422

3.  Targeted next generation sequencing as a diagnostic tool in epileptic disorders.

Authors:  Johannes R Lemke; Erik Riesch; Tim Scheurenbrand; Max Schubach; Christian Wilhelm; Isabelle Steiner; Jörg Hansen; Carolina Courage; Sabina Gallati; Sarah Bürki; Susi Strozzi; Barbara Goeggel Simonetti; Sebastian Grunt; Maja Steinlin; Michael Alber; Markus Wolff; Thomas Klopstock; Eva C Prott; Rüdiger Lorenz; Christiane Spaich; Sabine Rona; Maya Lakshminarasimhan; Judith Kröll; Thomas Dorn; Günter Krämer; Matthis Synofzik; Felicitas Becker; Yvonne G Weber; Holger Lerche; Detlef Böhm; Saskia Biskup
Journal:  Epilepsia       Date:  2012-05-21       Impact factor: 5.864

4.  Involvement of GATOR complex genes in familial focal epilepsies and focal cortical dysplasia.

Authors:  Sarah Weckhuysen; Elise Marsan; Virginie Lambrecq; Cécile Marchal; Mélanie Morin-Brureau; Isabelle An-Gourfinkel; Michel Baulac; Martine Fohlen; Christine Kallay Zetchi; Margitta Seeck; Pierre de la Grange; Bart Dermaut; Alfred Meurs; Pierre Thomas; Francine Chassoux; Eric Leguern; Fabienne Picard; Stéphanie Baulac
Journal:  Epilepsia       Date:  2016-05-13       Impact factor: 5.864

5.  Effects of distinct collybistin isoforms on the formation of GABAergic synapses in hippocampal neurons.

Authors:  Christoph Körber; Andrea Richter; Michaela Kaiser; Andrea Schlicksupp; Susanne Mükusch; Thomas Kuner; Joachim Kirsch; Jochen Kuhse
Journal:  Mol Cell Neurosci       Date:  2012-05-30       Impact factor: 4.314

6.  Familial cortical dysplasia caused by mutation in the mammalian target of rapamycin regulator NPRL3.

Authors:  Joe C Sim; Thomas Scerri; Miriam Fanjul-Fernández; Jessica R Riseley; Greta Gillies; Kate Pope; Hanna van Roozendaal; Julian I Heng; Simone A Mandelstam; George McGillivray; Duncan MacGregor; Lakshminarayanan Kannan; Wirginia Maixner; A Simon Harvey; David J Amor; Martin B Delatycki; Peter B Crino; Melanie Bahlo; Paul J Lockhart; Richard J Leventer
Journal:  Ann Neurol       Date:  2015-12-12       Impact factor: 10.422

7.  A balanced chromosomal translocation disrupting ARHGEF9 is associated with epilepsy, anxiety, aggression, and mental retardation.

Authors:  Vera M Kalscheuer; Luciana Musante; Cheng Fang; Kirsten Hoffmann; Celine Fuchs; Eloisa Carta; Emma Deas; Kanamarlapudi Venkateswarlu; Corinna Menzel; Reinhard Ullmann; Niels Tommerup; Leda Dalprà; Andreas Tzschach; Angelo Selicorni; Bernhard Lüscher; Hans-Hilger Ropers; Kirsten Harvey; Robert J Harvey
Journal:  Hum Mutat       Date:  2009-01       Impact factor: 4.878

8.  The GDP-GTP exchange factor collybistin: an essential determinant of neuronal gephyrin clustering.

Authors:  Kirsten Harvey; Ian C Duguid; Melissa J Alldred; Sarah E Beatty; Hamish Ward; Nicholas H Keep; Sue E Lingenfelter; Brian R Pearce; Johan Lundgren; Michael J Owen; Trevor G Smart; Bernhard Lüscher; Mark I Rees; Robert J Harvey
Journal:  J Neurosci       Date:  2004-06-23       Impact factor: 6.167

9.  Mutations in the mammalian target of rapamycin pathway regulators NPRL2 and NPRL3 cause focal epilepsy.

Authors:  Michael G Ricos; Bree L Hodgson; Tommaso Pippucci; Akzam Saidin; Yeh Sze Ong; Sarah E Heron; Laura Licchetta; Francesca Bisulli; Marta A Bayly; James Hughes; Sara Baldassari; Flavia Palombo; Margherita Santucci; Stefano Meletti; Samuel F Berkovic; Guido Rubboli; Paul Q Thomas; Ingrid E Scheffer; Paolo Tinuper; Joel Geoghegan; Andreas W Schreiber; Leanne M Dibbens
Journal:  Ann Neurol       Date:  2015-12-12       Impact factor: 10.422

10.  An integrated map of genetic variation from 1,092 human genomes.

Authors:  Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

View more
  11 in total

Review 1.  Gephyrin: a key regulatory protein of inhibitory synapses and beyond.

Authors:  Femke L Groeneweg; Christa Trattnig; Jochen Kuhse; Ralph A Nawrotzki; Joachim Kirsch
Journal:  Histochem Cell Biol       Date:  2018-09-27       Impact factor: 4.304

2.  ARHGEF9 mutations in epileptic encephalopathy/intellectual disability: toward understanding the mechanism underlying phenotypic variation.

Authors:  Jing-Yang Wang; Peng Zhou; Jie Wang; Bin Tang; Tao Su; Xiao-Rong Liu; Bing-Mei Li; Heng Meng; Yi-Wu Shi; Yong-Hong Yi; Na He; Wei-Ping Liao
Journal:  Neurogenetics       Date:  2017-11-13       Impact factor: 2.660

3.  De novo ARHGEF9 missense variants associated with neurodevelopmental disorder in females: expanding the genotypic and phenotypic spectrum of ARHGEF9 disease in females.

Authors:  Marcello Scala; Evelien Zonneveld-Huijssoon; Marianna Brienza; Oriano Mecarelli; Annemarie H van der Hout; Elena Zambrelli; Katherine Turner; Federico Zara; Angela Peron; Aglaia Vignoli; Pasquale Striano
Journal:  Neurogenetics       Date:  2020-09-17       Impact factor: 2.660

Review 4.  Rho GTPases in Intellectual Disability: From Genetics to Therapeutic Opportunities.

Authors:  Valentina Zamboni; Rebecca Jones; Alessandro Umbach; Alessandra Ammoni; Maria Passafaro; Emilio Hirsch; Giorgio R Merlo
Journal:  Int J Mol Sci       Date:  2018-06-20       Impact factor: 5.923

5.  Mutation p.R356Q in the Collybistin Phosphoinositide Binding Site Is Associated With Mild Intellectual Disability.

Authors:  Tzu-Ting Chiou; Philip Long; Alexandra Schumann-Gillett; Venkateswarlu Kanamarlapudi; Stefan A Haas; Kirsten Harvey; Megan L O'Mara; Angel L De Blas; Vera M Kalscheuer; Robert J Harvey
Journal:  Front Mol Neurosci       Date:  2019-03-12       Impact factor: 5.639

6.  A novel de novo hemizygous ARHGEF9 mutation associated with severe intellectual disability and epilepsy: a case report.

Authors:  Tong Qiu; Qian Dai; Qiu Wang
Journal:  J Int Med Res       Date:  2021-11       Impact factor: 1.671

7.  Human ARHGEF9 intellectual disability syndrome is phenocopied by a mutation that disrupts collybistin binding to the GABAA receptor α2 subunit.

Authors:  Dustin J Hines; April Contreras; Betsua Garcia; Jeffrey S Barker; Austin J Boren; Christelle Moufawad El Achkar; Stephen J Moss; Rochelle M Hines
Journal:  Mol Psychiatry       Date:  2022-02-15       Impact factor: 13.437

8.  Hyperactivity of Rac1-GTPase pathway impairs neuritogenesis of cortical neurons by altering actin dynamics.

Authors:  Valentina Zamboni; Maria Armentano; Gaia Berto; Elisa Ciraolo; Alessandra Ghigo; Donatella Garzotto; Alessandro Umbach; Ferdinando DiCunto; Elena Parmigiani; Marina Boido; Alessandro Vercelli; Nadia El-Assawy; Alessandro Mauro; Lorenzo Priano; Luisa Ponzoni; Luca Murru; Maria Passafaro; Emilio Hirsch; Giorgio R Merlo
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

9.  Biochemical and Morphological Characterization of a Guanine Nucleotide Exchange Factor ARHGEF9 in Mouse Tissues.

Authors:  Kyoko Ibaraki; Makoto Mizuno; Hitomi Aoki; Ayumi Niwa; Ikuko Iwamoto; Akira Hara; Hidenori Tabata; Hidenori Ito; Koh-Ichi Nagata
Journal:  Acta Histochem Cytochem       Date:  2018-06-20       Impact factor: 1.938

10.  Chromodomain-helicase-DNA-binding protein 1-like (CHD1L) silencing inhibits gastric cancer cell proliferation, invasion, and migration.

Authors:  Dinuo Li; Chen Li; Yu Wang; Yubin Wang; Qiang Li; Lei Wang
Journal:  Transl Cancer Res       Date:  2020-11       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.